Xtant Medical Holdings Inc (XTNT)
0.7252
+0.03
(+4.74%)
USD |
NYAM |
May 17, 16:00
0.7252
0.00 (0.00%)
Pre-Market: 20:00
Xtant Medical Holdings SG&A Expense (Annual): 64.29M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 64.29M |
| December 31, 2022 | 37.98M |
| December 31, 2021 | 35.47M |
| December 31, 2020 | 34.49M |
| December 31, 2019 | 43.84M |
| December 31, 2018 | 45.74M |
| December 31, 2017 | 55.84M |
| December 31, 2016 | 60.09M |
| Date | Value |
|---|---|
| December 31, 2015 | 41.97M |
| December 31, 2014 | 25.93M |
| December 31, 2013 | 26.22M |
| December 31, 2012 | 27.18M |
| December 31, 2011 | 27.11M |
| December 31, 2010 | 19.00M |
| December 31, 2009 | 8.038M |
| December 31, 2008 | 0.0886M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
34.49M
Minimum
2020
64.29M
Maximum
2023
43.21M
Average
37.98M
Median
2022
SG&A Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.06M |
| Retractable Technologies Inc | 20.01M |
| InfuSystems Holdings Inc | 58.03M |
| Asensus Surgical Inc | 36.08M |
| Catheter Precision Inc | 17.12M |